# DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry

> **NCT03825094** · — · UNKNOWN · sponsor: **Osprey Medical, Inc** · enrollment: 10000 (estimated)

## Conditions studied

- Patients at Risk for Developing Contrast-induced Nephropathy

## Interventions

- **DEVICE:** DyeVert™ Contrast Reduction Systems

## Key facts

- **NCT ID:** NCT03825094
- **Lead sponsor:** Osprey Medical, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-07
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2022-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03825094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03825094, "DyeVert™ System for Contrast Monitoring in At-Risk Patients Undergoing Angiography: A Real-World Registry". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03825094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*